Related references
Note: Only part of the references are listed.Clinical significance of blood-based miRNAs as diagnostic and prognostic nucleic acid markers in breast cancer: Comparative to conventional tumor markers
Menha Swellam et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
P53-induced miR-1249 inhibits tumor growth, metastasis, and angiogenesis by targeting VEGFA and HMGA2
Xiaoxiang Chen et al.
CELL DEATH & DISEASE (2019)
MicroRNA-3162-5p-Mediated Crosstalk between Kallikrein Family Members Including Prostate-Specific Antigen in Prostate Cancer
Farhana Mating et al.
CLINICAL CHEMISTRY (2019)
Long non-coding RNA MIF-AS1 promotes breast cancer cell proliferation, migration and EMT process through regulating miR-1249-3p/HOXB8 axis
Jinhua Ding et al.
PATHOLOGY RESEARCH AND PRACTICE (2019)
Exosomal miRNA profile as complementary tool in the diagnostic and prediction of treatment response in localized breast cancer under neoadjuvant chemotherapy
Alba Rodriguez-Martinez et al.
BREAST CANCER RESEARCH (2019)
Identification of Candidate miRNA Biomarkers for Glaucoma
Allyson G. Hindle et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2019)
Prognostic value of circulating microRNAs on heart failure-related morbidity and mortality in two large diverse cohorts of general heart failure patients
Antoni Bayes-Genis et al.
EUROPEAN JOURNAL OF HEART FAILURE (2018)
Serially measured circulating microRNAs and adverse clinical outcomes in patients with acute heart failure
Nick van Boven et al.
EUROPEAN JOURNAL OF HEART FAILURE (2018)
Circulating Tumor DNA Analysis in Patients With Cancer American Society of Clinical Oncology and College of American Pathologists Joint Review
Jason D. Merker et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2018)
The future of blood-based biomarkers for the early detection of breast cancer
Sau Yeen Loke et al.
EUROPEAN JOURNAL OF CANCER (2018)
MicroRNA-6869-5p acts as a tumor suppressor via targeting TLR4/NF-B signaling pathway in colorectal cancer
Shushan Yan et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Detection and localization of surgically resectable cancers with a multi-analyte blood test
Joshua D. Cohen et al.
SCIENCE (2018)
CTBP1 and metabolic syndrome induce an mRNA and miRNA expression profile critical for breast cancer progression and metastasis
Paula L. Farré et al.
Oncotarget (2018)
Breast cancer cell-free DNA (cfDNA) profiles reflect underlying tumor biology: The Circulating Cell-Free Genome Atlas (CCGA) study
Minetta C. Liu et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Development of a comprehensive cell-free DNA (cfDNA) assay for early detection of multiple tumor types: The Circulating Cell-free Genome Atlas (CCGA) study.
Eric A. Klein et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Altered microRNA profiles in plasma exosomes from mesial temporal lobe epilepsy with hippocampal sclerosis
Shaofeng Yan et al.
ONCOTARGET (2017)
Induced MiR-1249 expression by aberrant activation of Hedegehog signaling pathway in hepatocellular carcinoma
Yibiao Ye et al.
EXPERIMENTAL CELL RESEARCH (2017)
Identification of non-invasive miRNAs biomarkers for prostate cancer by deep sequencing analysis of urinary exosomes
Marta Rodriguez et al.
MOLECULAR CANCER (2017)
Measuring plasma levels of three microRNAs can improve the accuracy for identification of malignant breast lesions in women with BI-RADS 4 mammography
Julia Alejandra Pezuk et al.
ONCOTARGET (2017)
Diagnostic potential for a serum miRNA neural network for detection of ovarian cancer
Kevin M Elias et al.
eLife (2017)
The potential of liquid biopsies for the early detection of cancer
Ellen Heitzer et al.
NPJ PRECISION ONCOLOGY (2017)
Identification of Developmental Endothelial Locus-1 on Circulating Extracellular Vesicles as a Novel Biomarker for Early Breast Cancer Detection
Pyong-Gon Moon et al.
CLINICAL CANCER RESEARCH (2016)
Factors Associated With Rates of False-Positive and False -Negative Results From Digital Mammography Screening: An Analysis of Registry Data
Heidi D. Nelson et al.
ANNALS OF INTERNAL MEDICINE (2016)
Circulating microRNAs in cancer: Hope or hype?
Rajbir Singh et al.
CANCER LETTERS (2016)
Novel combination of serum microRNA for detecting breast cancer in the early stage
Akihiko Shimomura et al.
CANCER SCIENCE (2016)
Study of microRNAs-21/221 as potential breast cancer biomarkers in Egyptian women
Tarek Mohamed Kamal Motawi et al.
GENE (2016)
Plasma lipidomics profiling identified lipid biomarkers in distinguishing early-stage breast cancer from benign lesions
Xiaoli Chen et al.
ONCOTARGET (2016)
The role of MicroRNAs in human cancer
Yong Peng et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2016)
National Expenditure For False-Positive Mammograms And Breast Cancer Overdiagnoses Estimated At $4 Billion A Year
Mei-Sing Ong et al.
HEALTH AFFAIRS (2015)
Aberrant Methylation of APC and RARβ2 Genes in Breast Cancer Patients
Menha Swellam et al.
IUBMB LIFE (2015)
A Large-Scale Analysis of Genetic Variants within Putative miRNA Binding Sites in Prostate Cancer
Shane Stegeman et al.
CANCER DISCOVERY (2015)
Challenges in Using Circulating miRNAs as Cancer Biomarkers
Paola Tiberio et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Circulating MicroRNA Biomarker Studies: Pitfalls and Potential Solutions
Kenneth W. Witwer
CLINICAL CHEMISTRY (2015)
Clinical relevance of circulating cell-free microRNAs in cancer
Heidi Schwarzenbach et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
MicroRNAs in cancer: biomarkers, functions and therapy
Josie Hayes et al.
TRENDS IN MOLECULAR MEDICINE (2014)
Circulating levels and clinical implications of epithelial membrane antigen and cytokeratin-1 in women with breast cancer: can their ratio improve the results?
Abdelfattah M. Attallah et al.
TUMOR BIOLOGY (2014)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
Serum microRNA expression levels can predict lymph node metastasis in patients with early-stage cervical squamous cell carcinoma
Junying Chen et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2013)
Dampening Enthusiasm for Circulating MicroRNA in Breast Cancer
Rom S. Leidner et al.
PLOS ONE (2013)
Plasma MicroRNA Panel for Minimally Invasive Detection of Breast Cancer
Katarina Cuk et al.
PLOS ONE (2013)
Individual and combined effects of DNA methylation and copy number alterations on miRNA expression in breast tumors
Miriam Ragle Aure et al.
GENOME BIOLOGY (2013)
Diagnostic potential of PTEN-targeting miR-214 in the blood of breast cancer patients
Heidi Schwarzenbach et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
MicroRNA profiling: approaches and considerations
Colin C. Pritchard et al.
NATURE REVIEWS GENETICS (2012)
Identification of pathogenesis-related microRNAs in hepatocellular carcinoma by expression profiling
Yuki Katayama et al.
ONCOLOGY LETTERS (2012)
Cumulative Probability of False-Positive Recall or Biopsy Recommendation After 10 Years of Screening Mammography A Cohort Study
Rebecca A. Hubbard et al.
ANNALS OF INTERNAL MEDICINE (2011)
A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes
O. A. Kent et al.
ONCOGENE (2006)
Benign breast diseases: Classification, diagnosis, and management
Merih Guray et al.
ONCOLOGIST (2006)
Premalignant and in situ breast disease: Biology and clinical implications
G Arpino et al.
ANNALS OF INTERNAL MEDICINE (2005)
Tumor markers in breast cancer - European Group on Tumor Markers recommendations
R Molina et al.
TUMOR BIOLOGY (2005)
Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: An analysis of 27,825 patient evaluations
TM Kolb et al.
RADIOLOGY (2002)
Share Paper
